TNF
From WikiLectures
This article has been translated from WikiSkripta; ready for the editor's review.
Tumor necrosis factor (TNF) is the best known cytokine of the TNF family. It is released from a number of cell types, especially activated macrophages. One of the acute phase reactants is endogenous pyrogen. TNF signaling can, among other things, activate apoptosis and thus, inter alia, inhibit tumor growth (hence the name). Long-term TNF signaling leads to cachexia (hence the name). TNF dysregulation appears to be involved in the pathogenesis of many diseases. Anti-TNF therapy is being tested in the treatment of autoimmune diseases in particular.
Links[edit | edit source]
Related articles[edit | edit source]
External links[edit | edit source]
- WAJANT, H, K PFIZENMAIER a P SCHEURICH. Tumor necrosis factor signaling. Cell Death Differ [online]. 2003, vol. 10, no. 1, s. 45-65, dostupné také z <http://www.nature.com/cdd/journal/v10/n1/pdf/4401189a.pdf>. ISSN 1350-9047.
- DE PAEPE, B, KK CREUS a JL DE BLEECKER. The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy. Clin Dev Immunol [online]. 2012, vol. 2012, s. 369432, dostupné také z <https://www.hindawi.com/journals/jir/2012/369432/>. ISSN 1740-2530.
- SONAR, S a G LAL. Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity. Front Immunol [online]. 2015, vol. 6, s. 364, dostupné také z <https://www.frontiersin.org/articles/10.3389/fimmu.2015.00364/full>. ISSN 1664-3224.
- ŠEDÝ, J, V BEKIARIS a CF WARE. Tumor necrosis factor superfamily in innate immunity and inflammation. Cold Spring Harb Perspect Biol [online]. 2015, vol. 7, no. 4, s. a016279, dostupné také z <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382740/?tool=pubmed>. ISSN 1943-0264.
- BENDTZEN, K. Immunogenicity of Anti-TNF-α Biotherapies: I. Individualized Medicine Based on Immunopharmacological Evidence. Front Immunol [online]. 2015, vol. 6, s. 152, dostupné také z <https://www.frontiersin.org/articles/10.3389/fimmu.2015.00152/full>. ISSN 1664-3224.
- BENDTZEN, K. Immunogenicity of Anti-TNF-α Biotherapies: II. Clinical Relevance of Methods Used for Anti-Drug Antibody Detection. Front Immunol [online]. 2015, vol. 6, s. 109, dostupné také z <https://www.frontiersin.org/article/10.3389/fimmu.2015.00109/full>. ISSN 1664-3224.
